Dr. Neil E. Doherty III, MD

Dr. Doherty practices at Huntington Ambulatory Surgery Center - HOPD in Pasadena, California.

Dr. Doherty's NPI, 1871562017, was assigned on March 17, 2006. Dr. Doherty graduated from Harvard Medical School in 1982. Dr. Doherty holds California license G51688.

Dr. Doherty's primary practice is Huntington Ambulatory Surgery Center - HOPD, at 625 S Fair Oaks Ave, Pasadena, CA 91105.

Dr. Doherty's primary practice is Huntington Ambulatory Surgery Center - HOPD in Pasadena, California. Dr. Doherty is also affiliated with Emanate Health Inter-Community Hospital. The medical group on file is Foothill Cardiology Medical Group. Dmand AI also links Dr. Doherty to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doherty practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Doherty's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Doherty is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Doherty's licenses on file in 2 states: California and North Carolina.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic hypertension, coronary artery disease and deep vein thrombosis (DVT) among the conditions Dr. Doherty treats.

CMS data shows 1,388 Medicare services from Dr. Doherty across 8 procedure codes in 2024, for 399 Medicare patients. Medicare paid $86,993 for them. Every service was in an office.

CMS counts 399 Medicare patients who saw Dr. Doherty in 2024. The largest group is 75 to 84, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Doherty's median patient age at 73, with 46% women.

In 2024, Dr. Doherty wrote 2,633 Medicare Part D claims for 332 patients. 82% of them were for generic drugs. CMS names the drug for 2,274 of them, across 37 drugs with 11 or more claims each, at $396,905 in total drug cost. In 2023, CMS named 2,979 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Doherty for performance year 2024, reported as part of a group. Dr. Doherty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Doherty as offering telehealth.

Dmand AI links 9 papers to Dr. Doherty. The most frequent topics are Myocardium, Lactates and Adenine Nucleotides. Dr. Doherty has published most often in Circulation. Dr. Doherty's most frequent co-authors are Louis A. Brunsting, MD, Michael E. Jessen, MD and Patricia Gisela Cavero, MD.

CMS Open Payments shows 723 general payments to Dr. Doherty from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Medtronic, Inc. paid the most, $2,210.

Dmand AI lists 2 awards for Dr. Doherty, most recently Founding Fellow in 1993.

Dr. Doherty graduated from Harvard Medical School in 1982. Dr. Doherty is a member of ACC.

Dr. Doherty is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.